Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners
Tribe Technology set to deliver healthy pipeline of orders from Tier-One minersView Video
Andrada Mining acquisition elevates the miner to emerging mid-tier status
Andrada Mining acquisition elevates the miner to emerging mid-tier statusView Video

Latest Share Chat

Thursday broker round-up UPDATE

Thu, 19th Dec 2013 08:27

AstraZeneca: Alphavalue lowers target price from 3169p to 3087.7p and downgrades from reduce to sell.British American Tabacco: Panmure Gordon reduces target price from 3800p to 3200p and downgrades from buy to hold.Britvic: Investec ups target price from 600p to 672p and maintains a hold recommendation.BTG: N+1 Singer initiates with a target price of 490p and a sell recommendation.Centamin: Investec shapes target price from 54p to 51p retaining its buy recommendation.Domino Printing Sciences: Investec increases target price from 670p to 770p upgrading from hold to buy.Drax Group: Alphavalue shifts target price from 836.7p to 837p upgrading from reduce to add.eServGlobal: Canaccord Genuity initiates with a target price of 48p and a buy recommendation.Essar Energy: Barclays downgrades to equal-weight with a target price of 70p.Goldenport: Panmure Gordon ups target price from 50p to 60p and keeps a buy recommendation.Ophir Energy: Credit Suisse moves target price from 440p to 447p leaving its outperform rating unchanged.Probability: Numis cuts target price to 55p and downgrades from buy to add.Rightmove: Investec re-initiates with a target price of 2500p and a hold recommendation.Rockhopper Exploration: Canaccord Genuity shifts target price from 365p to 370p retaining a buy recommendation.Sainsbury: Alphavalue lowers target price from 351.2p to 350.6p, while upgrading from sell to reduce.Shire: Credit Suisse raises target price from 2750p to 2900p and reiterates a neutral rating.Speedy Hire: Panmure Gordon takes target price from 52p to 69p and maintains a buy recommendation.Sports Direct: Numis increases target price from 800p to 850p and stays with its add rating.Vectura: FinnCap ups target price to 180p and keeps a buy recommendation. Canaccord Genuity moves target price from 125p to 150p and leaves its buy recommendation unchanged.Victoria: Cantor Fitzgerald raises target price from 300p to 425p and maintains a buy recommendation.Xchanging: Panmure Gordon increases target price from 160p to 190p reiterating a buy recommendation.

Related Shares

More News
27 Jun 2024 13:00

German vaccine panel endorses Astra-Sanofi's RSV shot for infants

FRANKFURT, June 27 (Reuters) - Germany's influential vaccine advisory panel said on Thursday all infants in the country should receive AstraZeneca a...

26 Jun 2024 08:40

TOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in China

(Alliance News) - AstraZeneca PLC on Wednesday celebrated the approval of Tagrisso plus chemotherapy for a cancer form in China, a day after a similar...

25 Jun 2024 09:05

TOP NEWS: AstraZeneca details mixed findings from cancer drug trials

(Alliance News) - AstraZeneca PLC on Tuesday announced a mixed bag of results for two of its leading cancer drugs Imfinzi and Tagrisso.

25 Jun 2024 07:48

LONDON BRIEFING: Mixed bag for Astra drug; Landsec ups Bluewater stake

(Alliance News) - London's FTSE 100 is set to tread water on Tuesday, with a slump for US tech shares overnight keeping a lid on enthusiasm.

25 Jun 2024 07:17

AstraZeneca posts mixed results from recent Imfinzi trials

(Sharecast News) - AstraZeneca announced contrasting results from two phase three trials involving its immunotherapy drug 'Imfinzi', or durvalumab, on...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.